Harwood Feffer LLP Announces Investigation of Immucor, Inc.

NEW YORK--(BUSINESS WIRE)--Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Immucor, Inc. (“Immucor” or the “Company”) (NASDAQ: BLUD) concerning possible breaches of fiduciary duty and other violations of law related to the Company's agreement to be acquired by TPG Capital (“TPG”) in a transaction valued at approximately $1.973 billion.